Takeda (TSE:4502/NYSE:TAK) today announced new interim data from the Phase 1b, open-label, proof-of-concept study of ...

Takeda (TAK) announced new interim data from the Phase 1b, open-label, proof-of-concept study of subcutaneous mezagitamab, an anti-CD38 monoclonal ...

Biohaven (BHVN) downgraded after FDA setback for VYGLXIA. Learn key risks, pipeline shifts, and what investors should watch ...

SC GD Medical Admit Card 2025: The Staff Selection Commission (SSC) has officially issued the admit card for the Medical Test ...

The State Bank of India (SBI) has announced the SBI PO Mains Result 2025 on its official website sbi.co.in. Candidates can download the result PDF, check roll numbers of shortlisted candidates, and ...

Portfolio Receipts growth of 11% to $814 million; Royalty Receipts growth of 11% Net cash provided by operating activities of $703 million Raised ...

ORIGIN 3 trial primary endpoint results for Atacicept in IgA nephropathy (IgAN) selected as a featured late-breaking oral ...

Ahead of Children’s Day 2025 that is observed on November 14, Indian doctors highlight how parents and people can help children who stutter speak properly ...

KDIGO Guideline suggests treatment with Nefecon should be considered in the majority of patients at risk of progressive loss of kidney function ...

Bombardier (BBDb.TO) told investors on Thursday that stronger sales of aftermarket services would help the pure-play business ...

Pafos may have very little experience in the top continental competition, but the truth is that they have one mo ...

This strategic outlay reflects the company’s confidence in the market despite global headwinds, as it continues to build a ...